211
Participants
Start Date
April 30, 2012
Primary Completion Date
December 31, 2016
Study Completion Date
February 28, 2017
Mesalazine
2400 mg q.d. for 8 weeks
Placebo
3 tablets q.d. for 8 weeks
Sahlgrenska University Hospital, Gothenburg
Karolinska University Hospital, Huddinge
Norrland's University Hospital, Umeå
Collaborators (1)
Sahlgrenska University Hospital
OTHER
Smerud Medical Research International AS
OTHER
Alimenta AB
UNKNOWN
Tillotts Pharma AG
INDUSTRY
Karolinska University Hospital
OTHER
Haukeland University Hospital
OTHER
Oslo University Hospital
OTHER
Sykehuset Innlandet HF
OTHER
Hans Törnblom
OTHER